Biol Reprod Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print August 18, 2004.
Biol Reprod 2004, 10.1095/biolreprod.104.033480
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
72/1/42    most recent
biolreprod.104.033480v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.
Agricola
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.
BIOLOGY OF REPRODUCTION 72, 42–49 (2005)
DOI: 10.1095/biolreprod.104.033480
© 2005 by the Society for the Study of Reproduction, Inc.

Establishment and Maintenance of Human Embryonic Stem Cell Lines on Human Feeder Cells Derived from Uterine Endometrium under Serum-Free Condition1

Jung Bok Lee3,4, Jeoung Eun Lee3, Jong Hyuk Park3, Sun Jong Kim3, Moon Kyoo Kim4, Sung Il Roh3, and Hyun Soo Yoon2,3

Division of Stem Cell Biology,3 Medical Research Center, MizMedi Hospital, 157-280 Seoul, Korea Department of Life Science,4 College of Natural Sciences, Hanyang University, 133-791 Seoul, Korea


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Human embryonic stem (hES) cells are usually established and maintained on mouse embryonic fibroblast (MEFs) feeder layers. However, it is desirable to develop human feeder cells because animal feeder cells are associated with risks such as viral infection and/or pathogen transmission. In this study, we attempted to establish new hES cell lines using human uterine endometrial cells (hUECs) to prevent the risks associated with animal feeder cells and for their eventual application in cell-replacement therapy. Inner cell masses (ICMs) of cultured blastocysts were isolated by immunosurgery and then cultured on mitotically inactivated hUEC feeder layers. Cultured ICMs formed colonies by continuous proliferation and were allowed to proliferate continuously for 40, 50, and 55 passages. The established hES cell lines (Miz-hES-14, -15, and -9, respectively) exhibited typical hES cells characteristics, including continuous growth, expression of specific markers, normal karyotypes, and differentiation capacity. The hUEC feeders have the advantage that they can be used for many passages, whereas MEF feeder cells can only be used as feeder cells for a limited number of passages. The hUECs are available to establish and maintain hES cells, and the high expression of embryotrophic factors and extracellular matrices by hUECs may be important to the efficient growth of hES cells. Clinical applications require the establishment and expansion of hES cells under stable xeno-free culture systems.

cell line establishment, embryo, human embryonic stem cell lines, human endometrium, human feeder, xeno-free culture


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Human embryonic stem (hES) cells were first isolated from inner cell masses (ICMs) of human blastocysts by Thomson and colleagues [1]. The hES cells exhibit unique features, including continuous growth, a high level of telomerase activity, normal karyotypes, and differentiation capacity in vivo and in vitro. They express pluripotent cell-specific markers: strongly positive for stage-specific embryonic antigen (SSEA)-3 and -4, tumor rejection antigen (TRA)-1-60 and -81, and a high level of alkaline phosphatase (APase) activity, but are negative for SSEA-1 [17]. They also express Oct-4, a transcription factor that is specific to ICMs of blastocysts [3, 58]. Continuous proliferation of ES cells requires leukemia inhibitory factor (LIF) and/or a mitotically inactivated feeder cell layer in cultures of mouse embryonic stem (mES) cells. In contrast with the culturing of mES cells, feeder cell layers and basic fibroblast growth factor (bFGF) are necessary to maintain hES cells in an undifferentiated state with or without LIF, but LIF alone cannot support the continuous proliferation of hES cells with preventing the differentiation [1, 3, 9]. The hES cells are usually established and maintained on mouse embryonic fibroblast (MEF) feeder layers. Because animal feeder cells are associated with risks, including pathogen transmission and viral infection, and ethical problems, many stem cell researchers have investigated different culture conditions for hES cells, such as a feeder-free culture system. Extracellular matrices (ECMs) and MEF-conditioned (MEF-CM) medium were introduced to expand hES cells rather than the feeder cells. The hES cells cultured under these conditions show the same characteristics as hES cells cultured on MEF feeder layers [10]. However, this culture system also requires the massive and continuous culturing of MEF cells to obtain MEF-CM medium, and the possibilities of mouse retroviral infections and pathogen transmission remain [1113]. Attempts to prevent infections and pathogen transmission have involved the cultivation of hES cells on human feeder layers, such as fetal muscle, fetal skin, adult fallopian tubal epithelial cells [14], foreskin fibroblasts [6, 11], and adult marrow cells [15]. Additionally, Richards and colleagues [16] reported the testing of various human feeder cells derived from fetal (muscle, skin), adult (lung, skin, fallopian tube, muscle, endometrium), and neonatal (foreskin) tissues, and some of these cells are now available for use. The hES cells cultured on these various human feeder layers exhibit the same characteristics as MEF-based hES cells, including continuous proliferation, positive expression of specific markers (SSEA-3 and -4, TRA-1-60 and -81, APase, and Oct-4), normal karyotypes, and differentiation capacity. Although some feeder cells alter the shape of hES cell colonies, almost all hES cells cultured on human feeder cells maintain typical hES cell morphology, such as being round and small with a high nucleus-to-cytoplasm ratio, the notable presence of one to three nucleoli, and typical intercell spacing [6, 1116].

Human uterine endometrial cells (hUECs) regulate embryonic development and successful implantation in the reproductive track. Their growth and differentiation vary according to the menstrual cycle due to hormonal regulation. Throughout the menstrual cycle, hUECs express various factors, including growth factors (IGF, EGF, and TGFß) [1721], cytokines (CSF, LIF, and interleukin-1 and -6) [2227], and cell adhesion molecules (ECMs and integrin) [2831] to control embryonic development and allow successful implantation. Some of these factors (such as LIF and TGFß1) secreted in hUECs are known to be key regulators related to hES cell self-renewal. Additionally, various ECMs and cell adhesion molecules are expressed in hUECs, and these factors also have an important role in maintaining the undifferentiated state of hES cells [12].

In the present study, we examined the availability of hUECs as a feeder cell, attempted to establish and maintain new hES cell lines by using hUEC feeder cells, and confirmed the characteristics of newly established hES cell lines.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Preparation and Culture of Human Endometrial Cells

Human endometrium was obtained by biopsy following institutional review board (IRB) approval and the receipt of informed consent from the subjects. The obtained endometrium was minced finely and digested enzymatically with 0.25% collagenase (Sigma, St. Louis, MO) and 10 U/ml DNase I (Sigma) in DMEM/F-12 (GibcoBRL/Invitrogen, Grand Island, NY). Dissociated hUECs were cultured in DMEM/F-12 supplemented with 10% FBS (Hyclone, Logan, UT), 4 mM glutamine (GibcoBRL/Invitrogen), 20 mM HEPES, 100 U/ml penicillin, and 100 µg/ml streptomycin (Sigma).

Preparation of Feeder Layers

Cultured hUECs were mitotically inactivated with 10 µg/ml mitomycin C (Sigma) for 1.5 h and washed three times with PBS. Mitotically inactivated hUECs were then trypsinized with trypsin-EDTA (GibcoBRL/Invitrogen) and washed twice with culture medium. The dissociated hUECs were counted and plated on gelatin-coated four-well plates at 8.0 x 105 cells per well (Nunc, Roskilde, Denmark).

Culture of Human Embryos

Cryopreserved human pronuclear (PN)-stage embryos were donated following IRB approval and the receipt of informed consent by couples undergoing in vitro-fertilization treatment. Eight rapidly thawed PN-stage embryos were first cultured in G1.2 medium until the eight-cell stage, and then transferred to G2.2 medium (Vitrolife, Denver, CO) [7, 32]. After 3– 4 days of prolonged culture, seven fully expanded blastocysts were collected to isolate ICMs.

Immunosurgery

Cultured blastocysts were first removed from the zona pellucida using 0.5% Pronase (Sigma). These blastocysts were exposed to 100% anti-human-serum antibody (Sigma) for 20 min and washed three times with PBS for 5 min. Washed blastocysts were transferred to guinea pig complement (Life Technologies, Karlsruhe, Germany) at 37°C in 5% CO2 [32]. After 20 min, the blastocysts were washed and the isolated ICMs were transferred onto mitotically inactivated hUEC feeder layers.

Culture of hES Cells

Immunosurgery was performed on seven blastocysts to obtain their ICMs. To culture isolated ICMs, the culture medium for feeder cells was changed to DMEM/F12 containing 20% knockout serum replacement, 1 mM glutamine, 0.1 mM ß-mercaptoethanol, 1% nonessential amino acids, and 4 ng/ml bFGF (GibcoBRL/Invitrogen). Transferred ICMs were cultured on hUEC feeder layers for 6–8 days in the initial passage, after which the cultured cells formed colonies. These colonies were split onto newly prepared hUEC feeder layers, and the culture was prolonged. After 10 passages of the culture, the colonies were split every 5 days.

Immunocytochemistry

After 20 passages of the culture on hUEC feeder layers, hES cells were tested for the expression of pluripotent cell-specific markers. To detect APase activity, cultured cells were fixed with 4% paraformaldehyde. Fixed cells were permeabilized with 0.2% Triton X-100 and washed three times with PBS. APase staining was performed using a kit containing NBT/BCIP as the substrate (Roche Molecular Biochemicals, Indianapolis, IN). When continuously proliferating cells appeared dark blue, we observed the stained colony under light microscopy. The expressions of surface marker antigens were confirmed using SSEA-3, -4 (positive), and -1 (negative). Fixed cells were incubated with each primary antibody and were localized with biotinylated secondary antibody conjugated with avidin and horseradish peroxidase complex (Vectastain ABC system; Vector Laboratories, Burlingame, CA). The localization, color reaction, and visualization of red staining by light microscopy were performed using a Vector NovaRED substrate kit (Vector Laboratories).

Cell Line Identification and Karyotyping

We extracted each genomic DNA from Miz-hES-9, -14, -15, and hUEC and applied DNA fingerprinting using short tandem repeat (STR) loci amplified by PCR to identify established hES cell lines [32]. The STR loci that we used were D3S1358 (Chromosome 3p), vWA (12p12-pter), FGA (4q28), amelogenin (X:p22.1~22.3 &Y:p11.2), TH01 (11p15.5), TPOX (2p23-2per), CSF1PO (5q33.3-34), D5S818 (5p22-31), D13S317 (13q22~31) and D7S820 (7q11.21~22).

To analyze the karyotypes of hUEC feeder cells and hES cells, cell division was blocked by 0.1 µg/ml colcemid (Gibco/Invitrogen) in metaphase for 1–2 h. Cells were then trypsinized and resuspended in hypotonic KCl solution (Sigma), incubated for 20 min at 37°C, and fixed with 3:1 methanol:acetic acid. Chromosomes were visualized using G-band staining. More than 100 cells were examined in this way.

Differentiation of hES Cells In Vivo and In Vitro

The hES cell colonies that were cultured for longer than 20 passages on hUEC feeder layers were harvested clear of feeder cells. Prepared colonies were injected with a sterile 25-gauge needle into the right testis of 4-wk-old SCID-beige mice according to the statement on the use of animals in our institute. The injected mice were killed 12 wk after this injection and the resulting tumors were fixed with 4% paraformaldehyde and embedded in paraffin. The paraffin blocks were sectioned at 10 µm, stained with hematoxylin-eosin, and the tumors observed under a light microscope.

To confirm the differentiation of hES cells in vitro, they were harvested mechanically and washed to remove the feeder cells. Harvested hES cells were transferred into embryoid body (EB) culture medium (DMEM/F-12 supplemented with 20% serum replacement, 1 mM glutamine, 0.1 mM ß-mercaptoethanol, and 1% nonessential amino acids except for bFGF) and cultured continuously. At days 7, 14, and 24 after the beginning of culture, EBs were prepared for RNA isolation. Total RNA isolation from hES cells and differentiated cells was performed using TRIzol reagent according to the manufacturer's protocol (GibcoBRL/Invitrogen). Isolated RNA was quantified with a spectrophotometer (Spec3000; Bio-Rad, Hercules, CA) and reverse transcription (RT) was performed with 1 µg of total RNA in each sample. To confirm the differentiation ability of hES cells, PCR was performed with various differentiation-marker primers: ectoderm (NF-68: forward, acgctgaggaatggttcaag; reverse, tagacgcctcaatggtttcc; keratin: forward, aggcccaatacgaggagatt; reverse, atagccactggagatggtgg), mesoderm (CMP: forward, aaaaagggcaatgacaccag; reverse, ttgtgcagtctctgaggtgg; kallikrein: forward, gctttctcagccaggacatc; reverse, tattctttgcctcccaggtg; enolase: forward, gttcaatgtcatcaatggcg; reverse, gtgaacttctgccaagctcc), and endoderm ({alpha}-FP: forward, tgaaaaccctcttgaatgcc; reverse, tcttgcttcatcgtttgcag; {alpha}1-AT: forward, actgtcaacttcggggacac; reverse, ccccattgctgaagacctta). Oct-4 (forward, gacaacaatgagaaccttcaggaga; reverse, ttctggcgccggttacagaacca) was used as a positive control for undifferentiated hES cells [3, 58]. PCR cycles consisted of an initial denaturation step at 94°C for 5 min, followed by 30 cycles of 30 sec of denaturation at 94°C, 30 sec of annealing at 62°C, and 30 sec of extension at 72°C. A final extension was performed at 72°C for 10 min. PCR products were visualized by ethidium bromide staining following 1.5% agarose gel electrophoresis.

Flow Cytometry

To analyze the DNA content of hES cells, Miz-hES-9, -14, and -15 colonies were harvested with 0.1% collagenase IV (Sigma) and washed twice with PBS. These colonies were dissociated into single cells with 0.5 mM EDTA (Sigma). Separated cells were fixed with 70% ethanol at 4°C for more than 1 h and then washed clear. Fixed cells were stained with 100 µg/ml propidium iodide (Sigma) containing 100 µg/ml RNase, and measured by flow cytometry (Epics Altra; Beckman Coulter, Miami, FL).


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Culture of Primary hUECs

Three hUEC lines were isolated and cultured: two (Miz-endo1 and -2) from endometrial tissues obtained at the midproliferative phase, and the third (Miz-endo3) from the tissue obtained at the midluteal phase. Miz-endo1 and -2 could be cultured for more than 25 passages, whereas Miz-endo3 showed limited proliferation. Frozen-thawed hUECs isolated at the midproliferative phase exhibited similar growth characteristics. Miz-endo1 and -2 showed similar growth patterns, and hence we mainly used Miz-endo1 in this experiment. The morphology of Miz-endo1 cells was different from that of MEF feeder cells (Fig. 1). Miz-endo1 and -2 were split every 5 days because they reached confluence within a short period of time. At passage 3, cultured hUECs were first used as feeders to support the establishment and maintenance of hES cells and were used continuously until they became senescent.



View larger version (114K):
[in this window]
[in a new window]
 
PLATE I: FIG. 1. Phase contrast photographs of MEF (A) and hUEC (B) feeder cells. They showed obviously different morphology. MEF cells had a spiky and irregular outline, and hUECs were spindle-shaped. Each feeder cell was mitotically inactivated with mitomycin C and then plated onto gelatin-coated four-well plates at 8.0 x 105 cells per well. Bar = 100 µm. FIG. 2. The morphology of hES cell colonies expanded on MEF (A, E) or hUEC (BD, FH) feeder layers. Miz-hES-1 (A, E) expanded on MEF feeder layers showed typical hES cell morphology, such as being round and small with a high nucleus-to-cytoplasm ratio, the notable presence of nucleoli, and typical intercell spacing. The hUEC-based Miz-hES-9 (B, F), -14 (C, G), and -15 (D, H) also showed similar morphology to Miz-hES-1. However, the shape of hUEC-based hES cell colonies were thinner, flatter, and more angular than MEF-based Miz-hES-1. Bar = 200 µm (AD) and 100 µm (EH). FIG. 3. Immunocytochemical staining of undifferentiated hES cells established on hUEC feeder layers. Miz-hES-9, -14, and -15 expanded on hUEC feeder layers showed the same expression patterns of pluripotent cell-specific markers as MEF-based hES cells. The hUEC-based hES cells were positive for SSEA-3 (C, G, K) and -4 (D, H, L) and APase (A, E, I) but were negative for SSEA-1 (B, F, J). Bar = 200 µm

Maintenance of hES Cell Lines Established on hUEC Feeder Layers

In the culture of donated embryos, seven blastocysts were obtained from eight cultured PN-stage embryos, and the ICMs of these blastocysts were isolated by immunosurgery. Three transferred ICMs were attached to hUEC feeder layers and continuously proliferated in the initial passage. Proliferating cells formed colonies after 7–8 days in the culture, and these colonies were split onto newly prepared hUEC feeder layers. They exhibited slow proliferation compared with the growth of other hES cells (Miz-hES-1, National Institutes of Health registered) until passage 7 or 8. Miz-hES-9, -14, and -15 were in continuous cultures for 55, 40, and 50 passages, respectively. They have been split onto new feeder layers every 5–6 days. The hES cells cultured on hUEC feeder layers were thinner, flatter, and more angular than MEF-based hES cells, and boundaries between hES cells and feeder cells were more evident (Fig. 2).

Expression of Pluripotent Cell-Specific Markers

The expression of several cell-surface markers was confirmed by immunocytochemistry. Miz-hES-9, -14, and -15 expanded on hUEC feeder layers showed the same expression patterns of pluripotent cell-specific markers as MEF-based hES cells. The hUEC-based hES cells were positive for SSEA-3 and -4 and APase but were negative for SSEA-1 (Fig. 3). Feeder cells were negative for all surface makers used in this experiment.

DNA Finger Printing and Karyotype Analysis

All hES cell lines could be distinguishable because they showed different STR loci, including D3S1358 (chromosome 3p), vWA (12p12-pter), FGA (4q28), amelogenin (X: p22.1~22.3 &Y:p11.2), TH01 (11p15.5), TPOX (2p23-2per), CSF1PO (5q33.3~34), D5S818 (5p22-31), D13S317 (13q22~31), and D7S820 (7q11.21~22) (Fig. 4, A–C).



View larger version (85K):
[in this window]
[in a new window]
 
FIG. 4. DNA fingerprinting (AC) and karyotype analysis of Miz-hES-9, -14, -15 and hUEC (D). A) Isogenic analysis in loci D3S1358, vWA, and FGA. B) Isogenic analysis in loci Amelogenin, TH01, TPOX, and CSF1PO. C) Isogenic analysis in loci D5S818, D13S317, and D7S820. The matching probabilities are 7.8 x 10–15 for Miz-hES-9, 1.9 x 10–18 for Miz-hES-14, 1.6 x 10–19 for Miz-hES-15, and 3.7 x 10–15 for hUEC. The boxed numbers and corresponding peaks represent locations of polymorphisms for each short tandem repeat marker. D) Miz-hES-9, -14, -15 and hUECs showed normal 46, XX karyotypes

Karyotype analysis was performed with hUECs and hES cells expanded on hUEC feeder layers. Miz-endo1, and Miz-hES-9, -14, and -15 showed normal 46, XX karyotypes (Fig. 4D), as did the frozen-thawed hUECs (data not shown). Karyotype analysis was performed every 6 mo.

Formation of Teratomas and EBs

SCID-beige mice were killed 12 wk after being injected with undifferentiated hES cells to confirm the formation of teratomas. Teratomas had formed in the right testes of all three mice injected with Miz-hES-9, -14, and -15 and appeared as well-differentiated tumor-like structures, including kidney-like structure, primitive neural tube, skin, gastrointestinal epithelium, tooth-like structure, and cartilage (Fig. 5).



View larger version (139K):
[in this window]
[in a new window]
 
FIG. 5. Histological analysis of teratomas formed in the testes of SCID-beige mice by the injection of Miz-hES-9 (A, B), -14 (C, D), and -15 (E, F). Well-differentiated teratomas contain kidney-like structure (A), primitive neuroepithelial tubule (B), skin (C), gastrointestinal epithelium (D), tooth-like structure (E), and cartilage (F). Bar = 100 µm

EBs cultured for 7, 14, and 24 days in suspension also showed the expression of tissue-specific markers. Almost all of the tissue-specific markers were expressed in differentiated EBs, with the expression level gradually increasing with time from the induction of differentiation. However NF-68, kallikrein, and enolase were also expressed in undifferentiated hES cells, and the expression of Oct-4 gradually decreased in differentiated cells (Fig. 6).



View larger version (100K):
[in this window]
[in a new window]
 
FIG. 6. In vitro differentiation of hES cells established and expanded on hUEC feeder layers. To confirm the differentiation capacity of hUEC-based hES cells, total RNA was extracted from sphere-shaped 7-, 14- (A), and 24-day-old EB, and RT-PCR was performed to examine the expression of tissue-specific markers (B). The expression of keratin (ectoderm), CMP (mesoderm), {alpha}-FP, and {alpha}1-AT (endoderm) was gradually increased in a time-dependent manner in EBs. However, NF-68, kallikrein, and enolase were expressed in both undifferentiated hES cells and differentiated EBs. The expression of Oct-4 gradually decreased in differentiated cells. Bar = 100 µm

Proliferation Properties of hES Cells

MEF and hUEC feeder cells comprised 10.0% and 10.24% of proliferating cells, respectively, but the composition of proliferating cells was higher in Miz-hES-9 (47.6%), -14 (48.6%), and -15 (48.2%) lines than in feeder cells. Each hES cell line established and maintained on hUEC feeder layers showed a slightly higher composition of proliferating cells than MEF-based Miz-hES-3 (40.4%). Miz-hES-3 expanded on hUECs for more than 20 passages showed a slightly increased proportion of the cells in the S phase (44.6%; Fig. 7).



View larger version (31K):
[in this window]
[in a new window]
 
FIG. 7. Flow cytometric analysis of feeder cells and hES cells. Cultured hUECs (A), MEFs (B), and Miz-hES-9 (C), -14 (D), and -15 (E) were fixed and stained with propidium iodide. DNA content was measured by fluorescene-activated cell sorting analysis. Each feeder cell consisted of similar amounts of proliferating cells (about 10%). Proportion of Miz-hES-9 (47.6%), -14 (48.6%), and -15 (48.2%) in S phase was similar to each other. Miz-hES-3 (G, 44.6%) expanded on hUEC feeders showed slightly higher composition of proliferating cells than MEF-based Mz-hES3 (F, 40.4%)


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The hES cells are usually expanded on feeder layers to maintain an undifferentiated state. MEF cells have been used as feeder layers prepared from CF-1 mice at 13.5 days after fertilization, but animal feeder layers exhibit some problems in maintaining hES cells in an undifferentiated state. First, there is an ethical problem associated with animal feeder layers because hES cells directly interact with MEF cells to maintain continuous proliferation. Second, animal feeder layers are associated with risks of viral infection and pathogen transmission. Because the ultimate object of stem cell research is cell-based clinical therapy, hES cells should be expanded on human feeder layers or under feeder-free culture conditions. There are some previous reports on this, but there are some problems that MEF cells must be cultured to obtain MEF-CM continuously and MEF-CM still has the possibility of viral infection or pathogen transmission.

In feeder-free culture conditions for hES cells, ECMs, including laminin, collagen, and fibronectin, play an important role in maintaining hES cells in an undifferentiated state. In 2001, Xu and colleagues [10] were the first to demonstrate that the expression levels of integrin{alpha}6 and ß1 in hES cells cultured on Matrigel or laminin were similar to those in MEF-based hES cells, and that these ECM-based hES cells maintained typical hES cell characteristics. The expression level of laminin and proliferation capacity were slightly higher in hUECs and hES cells cultured on hUECs. We thought that the expression level of laminin in feeder cells may affect the maintenance of hES cells in an undifferentiated state and that other factors expressed in feeder cells, such as LIF and TGFß1, may regulate the growth of hES cells. There are previous reports that LIF and TGFß are expressed in normal human endometrium and regulate downstream signaling through the activation of JAK/STAT kinase and Smads, respectively. Oct-4 and Nanog are associated with hES cell self-renewal, and the expression of these factors is regulated by LIF, BMP, and TGFß [3335]. The hES cells maintained on hUEC feeder cells might be regulated by their proliferation and differentiation by spontaneous expression of these factors in hUEC feeder cells.

The hUECs directly interact with embryos and regulate the embryonic development and successful implantation in vivo. Although the characteristics of these cells differed with the endometrial phase, some factors, including ECMs, growth factors, and cytokines are expressed in hUECs throughout the menstrual cycle. Richards and colleagues [16] attempted to use hUECs as feeder cells to support the growth of hES cells and reported that adult glandular endometrium and adult stromal endometrium cannot maintain hES cells in an undifferentiated state. However, we have established and maintained three hES cell lines on hUEC feeder cells in our institute. Our different results may be attributable to the different endometrial phases used. Miz-endo1 and -2 obtained from the midproliferative phase can support the continuous growth of hES cells and maintain hES cells in an undifferentiated state, whereas Miz-endo3 obtained from the midluteal phase cannot.

The hUECs have the advantage that they can be used for many passages, whereas MEF feeder cells exhibit a limited number of passages when they were used as feeders. However, hUECs showed a similar capacity to support the continuous growth of hES cells before they become senescent. An hUECs feeder cell line can be used for more than 1 yr, allowing the long-term culturing of hES cells under stable conditions. In addition to this, human feeder cells are more convenient than primary cultured MEF feeder cells in terms of the absence of a requirement for animal facilities.

For the eventual application in cell-based therapy, hES cells should be free from the risks of pathogen transmission and viral infection, and it is ideal that hES cells are cultured under stable xeno-free culture condition. Until now, however, it has been hard to eliminate animal materials completely for establishment and expansion of hES cells. Immunosurgery, a common method to isolate ICMs of blastocysts, has been performed by using anti-human-serum antibody purified from rabbit and guinea pig complement [1, 3, 6, 7]. Although these materials do damage to only trophoectoderms, there is still a possibility of exposure to animal and/or viruses. Also, animal serum (usually FBS or FCS) has been used for attachment and growth of feeder cells to support the establishment and growth of hES cells [13, 6, 7, 11, 1416, 32]. Although hES cells are cultured under feeder-free condition risks of pathogen transmission and viral infection still remains because the materials from animal sources such as feeder-CM and ECM gel (usually Matrigel) have still been used for the growth of hES cells [10, 12, 13]. Up to now, there have been no hES cell lines established and maintained under complete xeno-free culture condition even though some have been represented as a xeno-free culture system for the culture of hES cells without animal serum and by preventing direct interaction with animal cells [14, 16]. In our experiment, we also partially used animal materials for immunosurgery and culture of hUECs. However, Miz-hES-9, -14, and -15 were established and maintained without direct interaction with animal cells and animal serum. Therefore, we thought that our results are in the process of becoming complete xeno-free culture conditions.

Our results demonstrate that hES cell lines can be established and maintained on hUEC feeder layers. Newly established hES cell lines have typical hES cell characteristics such as continuous growth, expression of cell surface markers, normal karyotype, and differentiation capacity. These hES cells show elevated proliferation capacity, which might be due to the effects of the expression levels of ECMs and embryotrophic factors in feeder cells (data not shown). The establishment and expansion of hES cells under a completely xeno-free culture system might be helpful to cell-based therapies. Therefore, continuous investigation for the improving culture condition should be performed to make complete xeno-free culture systems. These will lead us to obtaining available hES cells under xeno-free culture system in the near future.


    FOOTNOTES
 
1 Supported by grants (SC12021 and SC11012) from Stem Cell Research Center of the 21C Frontier R & D Program funded by the Ministry of Science and Technology, Republic of Korea. Back

2 Correspondence: Hyun Soo Yoon, Division of Stem Cell Biology, Medical Research Center, MizMedi Hospital, 701-4, Naebalsan-dong, Kangseo-ku, Seoul 157-280, Korea. FAX: 82 22 007 1852; yoon{at}mizmedi.net Back

Received: 24 June 2004.

First decision: 19 July 2004.

Accepted: 17 August 2004.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, Jones JM. Embryonic stem cell lines derived from human blastocysts. Science 1998 282:1145-1147[Abstract/Free Full Text]
  2. Amit M, Carpenter MK, Inokuma MS, Chiu CP, Harris CP, Waknitz MA, Itskovitz-Eldor J, Thomson JA. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000 227:271-278[CrossRef][Medline]
  3. Reubinoff BE, Pera M, Fong CY, Trounson A, Bongso A. Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 2000 18:399-404[CrossRef][Medline]
  4. Odorico JA, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001 19:193-204[Abstract/Free Full Text]
  5. Henderson JK, Draper JS, Baillie HS, Fishel S, Thomson JA, Moore H, Andrews PW. Preimplantation human embryos and embryonic stem cells show comparable expression of stage-specific embryonic antigens. Stem Cells 2002 20:329-337[Abstract/Free Full Text]
  6. Hovatta O, Mikkola M, Gertow K, Strömberg A, Inzunza J, Hreinsson J, Rozell B, Andäng M, Ährlund-Richter L. A culture system using human foreskin fibroblasts as feeder cells allows production of human embryonic stem cells. Hum Reprod 2003 18:1404-1409[Abstract/Free Full Text]
  7. Park JH, Kim SJ, Oh EJ, Moon SY, Roh SI, Yoon HS. Establishment and maintenance of human embryonic stem cells on STO, a permanently growing cell line. Biol Reprod 2003 69:2007-2014[Abstract/Free Full Text]
  8. Carpenter MK, Rosler E, Rao MS. Characterization and differentiation of human embryonic stem cells. Cloning Stem Cells 2003 5:79-88[CrossRef][Medline]
  9. Humphrey RK, Beattie GM, Lopez AD, Bucay N, King CC, Firpo MT, Rose-John S, Hayek A. Maintenance of pluripotency in human embryonic stem cells is STAT3 independent. Stem Cells 2004 22:522-530[Abstract/Free Full Text]
  10. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, Carpenter MK. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001 19:971-974[CrossRef][Medline]
  11. Amit M, Margulets V, Segev H, Shariki K, Laevsky I, Coleman R, Itskovitz-Eldor J. Human feeder layers for human embryonic stem cells. Biol Reprod 2003 68:2150-2156[Abstract/Free Full Text]
  12. Amit M, Shariki C, Margulets V, Itskovitz-Eldor J. Feeder layer- and serum-free culture of human embryonic stem cells. Biol Reprod 2003 70:837-845
  13. Rosler ES, Fisk GJ, Ares X, Irving J, Miura T, Rao MS, Carpenter MK. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev Dyn 2004 229:259-274[CrossRef][Medline]
  14. Richards M, Fong CY, Chan WK, Wong PC, Bongso A. Human feeders support prolonged undifferentiated growth of human inner cell masses and embryonic stem cells. Nat Biotechnol 2002 20:933-936[CrossRef][Medline]
  15. Cheng L, Hammond H, Ye Z, Zhan X, Dravid G. Human adult marrow cells support prolonged expansion of human embryonic stem cells in culture. Stem Cells 2003 21:131-142[Abstract/Free Full Text]
  16. Richards M, Tan S, Fong CY, Biswas A, Chan WK, Bongso A. Comparative evaluation of various human feeders for prolonged undifferentiated growth of human embryonic stem cells. Stem Cells 2003 21:546-556[Abstract/Free Full Text]
  17. Nayak NR, Giudice LC. Comparative biology of the IGF system in endometrium, decidua, and placenta, and clinical implications for foetal growth and implantation disorders. Placenta 2003 24:281-296[CrossRef][Medline]
  18. Giudice LC. Genes associated with embryonic attachment and implantation and the role of progesterone. J Reprod Med 1999 44:suppl 2165-171[Medline]
  19. Ingman WV, Robertson SA. Defining the actions of transforming growth factor beta in reproduction. Bioessays 2002 24:904-914[CrossRef][Medline]
  20. Tabibzadeh S. Homeostasis of extracellular matrix by TGF-beta and lefty. Front Biosci 2002 7:1231-1246
  21. Luo X, Xu J, Chegini N. The expression of Smads in human endometrium and regulation and induction in endometrial epithelial and stromal cells by transforming growth factor-beta. J Clin Endocrinol Metab 2003 88:4967-4976[Abstract/Free Full Text]
  22. Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, Wang Y, Yeung YG. Biology and action of colony-stimulating factor-1. Mol Reprod Dev 1997 46:4-10[CrossRef][Medline]
  23. Desai NN, Goldfarb JM. Growth factor/cytokine secretion by a permanent human endometrial cell line with embryotrophic properties. J Assist Reprod Genet 1996 13:546-550[CrossRef][Medline]
  24. Smith SK, Charnock-Jones DS, Sharkey AM. The role of leukemia inhibitory factor and interleukin-6 in human reproduction. Hum Reprod 1998 suppl 3237-243
  25. Lass A, Weiser W, Munafo A, Loumaye E. Leukemia inhibitory factor in human reproduction. Fertil Steril 2001 76:1091-1096[CrossRef][Medline]
  26. Simon C, Pellicer A, Polan ML. Interleukin-1 system crosstalk between embryo and endometrium in implantation. Hum Reprod 1995 suppl 243-54
  27. De los Santos MJ, Mercader A, Frances A, Portoles E, Remohi J, Pellicer A, Simon C. Role of endometrial factors in regulating secretion of components of the immunoreactive human embryonic interleukin-1 system during embryonic development. Biol Reprod 1996 54:563-574[Abstract]
  28. Jokimaa V, Oksjoki S, Kujari H, Vuorio E, Anttila L. Altered expression of genes involved in the production and degradation of endometrial extracellular matrix in patients with unexplained infertility and recurrent miscarriages. Mol Hum Reprod 2002 8:1111-1116[Abstract/Free Full Text]
  29. Gray CA, Bartol FF, Tarleton BJ, Wiley AA, Johnson GA, Bazer FW, Spencer TE. Developmental biology of uterine glands. Biol Reprod 2001 65:1311-1323[Abstract/Free Full Text]
  30. Selam B, Kayisli UA, Garcia-Velasco JA, Arici A. Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells. Biol Reprod 2002 66:1-5[Abstract/Free Full Text]
  31. Reddy KV, Mangale SS. Integrin receptors: the dynamic modulators of endometrial function. Tissue Cell 2003 35:260-273[CrossRef][Medline]
  32. Hwang WS, Ryu YJ, Park JH, Park ES, Lee EG, Koo JM, Jeon HY, Lee BC, Kang SK, Kim SJ, Ahn C, Hwang JH, Park KY, Cibelli JB, Moon SY. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004 303:1669-1674[Abstract/Free Full Text]
  33. Sato N, Sanjuan IM, Heke M, Uchida M, Naef F, Brivanlou AH. Molecular signature of human embryonic stem cells and its comparison with the mouse. Dev Biol 2003 260:404-413[CrossRef][Medline]
  34. Nakashima K, Colamarino S, Gage FH. Embryonic stem cells: staying plastic on plastic. Nat Med 2004 10:23-24[CrossRef][Medline]
  35. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med 2004 10:55-63[CrossRef][Medline]



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
C. E. Gargett, K. E. Schwab, R. M. Zillwood, H. P.T. Nguyen, and D. Wu
Isolation and Culture of Epithelial Progenitors and Mesenchymal Stem Cells from Human Endometrium
Biol Reprod, June 1, 2009; 80(6): 1136 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J R Soc InterfaceHome page
M. R Placzek, I-M. Chung, H. M Macedo, S. Ismail, T. Mortera Blanco, M. Lim, J. Min Cha, I. Fauzi, Y. Kang, D. C.L Yeo, et al.
Stem cell bioprocessing: fundamentals and principles
J R Soc Interface, March 6, 2009; 6(32): 209 - 232.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
C. Unger, H. Skottman, P. Blomberg, M. Sirac Dilber, and O. Hovatta
Good manufacturing practice and clinical-grade human embryonic stem cell lines
Hum. Mol. Genet., April 15, 2008; 17(R1): R48 - R53.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc BHome page
P. Batten, N. A Rosenthal, and M. H Yacoub
Immune response to stem cells and strategies to induce tolerance
Phil Trans R Soc B, August 29, 2007; 362(1484): 1343 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
F. Mannello and G. A. Tonti
Concise Review: No Breakthroughs for Human Mesenchymal and Embryonic Stem Cell Culture: Conditioned Medium, Feeder Layer, or Feeder-Free; Medium with Fetal Calf Serum, Human Serum, or Enriched Plasma; Serum-Free, Serum Replacement Nonconditioned Medium, or Ad Hoc Formula? All That Glitters Is Not Gold!
Stem Cells, July 1, 2007; 25(7): 1603 - 1609.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Mantel, Y. Guo, M. R. Lee, M.-K. Kim, M.-K. Han, H. Shibayama, S. Fukuda, M. C. Yoder, L. M. Pelus, K.-S. Kim, et al.
Checkpoint-apoptosis uncoupling in human and mouse embryonic stem cells: a source of karyotpic instability
Blood, May 15, 2007; 109(10): 4518 - 4527.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
C. Allegrucci and L.E. Young
Differences between human embryonic stem cell lines
Hum. Reprod. Update, March 1, 2007; 13(2): 103 - 120.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
H. Skottman and O. Hovatta
Culture conditions for human embryonic stem cells.
Reproduction, November 1, 2006; 132(5): 691 - 698.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Trounson
The Production and Directed Differentiation of Human Embryonic Stem Cells
Endocr. Rev., April 1, 2006; 27(2): 208 - 219.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
72/1/42    most recent
biolreprod.104.033480v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow My Folders
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.
Agricola
Right arrow Articles by Lee, J. B.
Right arrow Articles by Yoon, H. S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS